Australian finance news, stock quotes, currency information and blogs. Back. Xspray Pharma AB (publ) (XSPRAY.ST) Add to watchlist. Stockholm - Stockholm Real-time price. Currency in SEK. 111.00 +3.00 (+2.78%) At close: 5:29PM CET.

XSpray Pharma AB Registered Shs Stock 107.00 SEK 0.00 0.00% 12:00:00 PM EDT 3/31/2021 STO. Add to watchlist Start Trading >> Plus500. 76.4% of retail CFD accounts lose money. News More

It employs technology platform in order to create a pipeline of anti-cancer products. The Company primarily develops protein kinase inhibitors (PKI) for targeted cancer treatments. XSPRAY PHARMA AB (PUBL) 0GHZ Overview - Search stock, chart, recent trades, company information, trading information, company news, fundamentals Xspray Pharma AB (publ), a pharmaceutical company, develops protein kinase inhibitors for targeted cancer treatments in Sweden. Its product candidates include HyNap-Nilo, HyNap-Sora, and HyNap-Dasa. Xspray Pharma General Information Description. XSpray Pharma AB is a product development company with several product candidates in clinical development. It develops, sells and licenses generic versions of marketed cancer drugs, protein kinase inhibitors.

The company was founded by Mustafa Demirbüker and Håkan Nykvist in November 2003 and is headquartered in Solna, Sweden. 2021-03-26 · Discover historical prices for XSPRAY.ST stock on Yahoo Finance. View daily, weekly or monthly format back to when Xspray Pharma AB stock was issued. Xspray Pharma AB är ett svenskt läkemedelsforskningföretag, som utvecklar metoder för produktion av läkemedel med amorf struktur. Xspray Pharma AB grundades 2003 som XSpray Microparticles AB. Xspray Pharmas aktier noterades 2017 på First North och 2020 på Stockholmsbörsens huvudlista. Visa XSPRAY PHARMA AB-diagram live för att se aktiens kursutveckling. Hitta marknadsprognoser, finansiella XSPRAY-data och marknadsnyheter.

XSPRAY.ST.

Senaste nyheter om - Xspray Pharma, aktieanalys, kursutveckling och rapporter. Xspray Pharma komplett bolagsfakta & börsnyheter från Analysguiden. Prenumerera här.

XSPRAY. Delayed Quote. Delayed - 04/23 11:29:52 Get the latest XSpray Pharma Registered stock price and detailed information including news, historical charts and realtime prices.

Xspray Pharma / ANDA vs 505 (b) (2) / ANDA vs 505 (b) (2) idag 12:42 Generika måste vara helt identisk med originalprodukten ifråga om dos, administration, upptag etc. Kan man visa detta registrerar man via ANDA och produkten kallas då generika.

The company primarily develops protein kinase inhibitors (PKI) for targeted cancer treatment. Xspray Pharma aims to submit its improved version of dasatinib for market approval application in second half of 2021; 2021-03-18 16:00 · MFN Xspray Pharma avser att lämna in ansökan om marknadsgodkännande av den förbättrade versionen av dasatinib under andra halvåret 2021; 2021-03-05 15:11 · Nyhetsbyrån Direkt Company profile page for XSpray Pharma AB including stock price, company news, press releases, executives, board members, and contact information XSPRAY PHARMA AB (PUBL) : News, information and stories for XSPRAY PHARMA AB Stock quotes are provided by Factset, Morningstar and S&P Capital IQ 2021-04-06 · The latest Xspray Pharma AB share price. View recent trades and share price information for Xspray Pharma AB and other shares. Xspray Pharma utvecklar läkemedel genom att kombinera välkända och väldokumenterade cancerläkemedel med egen innovativ patenterad teknologi. Målet är att, genom medicinska fördelar och en unik patentsituation, kunna börja marknadsföra läkemedelsprodukter i främst USA med höga marginaler p.g.a. den gynsamma patentsituationen som skapas för produkter utvecklade med bolagets Visa XSPRAY PHARMA AB-diagram live för att se aktiens kursutveckling.

Målet är att, genom medicinska fördelar och en unik patentsituation, kunna börja marknadsföra läkemedelsprodukter i främst USA med höga marginaler p.g.a.
Vad menas med sa kallad defensiv korning

But momentum on its own is no guarantee of future returns. To get a better idea about whether this momentum will continue, it's worth doing some investigation yourself.

Fall: Vinst 34503 SEK i 2 veckor — Ascelia pharma forum. CMC har sålt och delat ut sina aktier i BTkanalen_BT_228_.png (614×387). Dagsgraf med BT-kanalen från Metastock.
Vilka fastigheter ager en person

reumatologi uppsala
csn lanka
vem får företräda polismyndigheten
daniel ståhl flashback
kollaborationsbier jester king

Xspray Pharma was previously listed on the Nasdaq First North Growth Market. Founded in 2003, Xspray Pharma is a product development company with multiple product candidates in clinical development. Xspray uses its innovative, patented RightSize technology to develop improved and generic versions of marketed drugs, primarily protein kinase inhibitors (PKIs) for the treatment of cancer.

By way of example, Xspray Pharma has seen its share price rise 120% over the last year, delighting many shareholders.But while the successes are well known, investors should not ignore the very many unprofitable companies that simply burn through all their cash and collapse. 2021-03-16 Xspray Pharma has broken the falling trend channel This is the body text of the blog post to give visitors an idea of what the post is about beyond just the title. It can be a long snippet, a short snippet, whatever you prefer the size of card and description to be.This is the body text of the blog post to give visitors an idea of what the post is about beyond just the title.